CHAMPION-AF Trial Finds LAAC an Alternative for NOAC in Lower-Risk Patients – Medscape


  1. CHAMPION-AF Trial Finds LAAC an Alternative for NOAC in Lower-Risk Patients  Medscape
  2. CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints  PR Newswire
  3. New Frontiers in AFib: Heart Device Noninferior to Blood Thinners in Stroke Prevention, Wins on Safety  pharmacytimes.com
  4. Treating AFib with a single procedure proves to be safer, more effective  News4JAX
  5. Six Reasons Why CHAMPION-AF Should Not Change Practice  Medscape